BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

37.30 +0.52 (+1.41%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 4 Next >

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

September 10, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

BioLife Solutions (NASDAQ:BLFS) Combines Strong Growth With a High-Quality Technical Setup ↗

September 10, 2026

Via Chartmill

BioLife Solutions (NASDAQ:BLFS) Combines High Growth Momentum with a Breakout Setup ↗

September 04, 2026

Via Chartmill

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders

August 29, 2026

From Halper Sadeh LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether UTZ, BLFS, FNWD, PSNL are Obtaining Fair Deals for their Shareholders

July 30, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone ↗

May 07, 2026

Via Chartmill

Topics Earnings

BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Halper Sadeh LLC is Investigating Whether UTZ, BLFS, NRIM are Obtaining Fair Deals for their Shareholders

July 29, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether UTZ, BLFS, NG are Obtaining Fair Deals for their Shareholders

July 28, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

July 24, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders

July 22, 2026

From Halper Sadeh LLC

Via Business Wire

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Exploring BioLife Solns's Earnings Expectations ↗

May 07, 2025

Via Benzinga

Analyst Expectations For BioLife Solns's Future ↗

November 18, 2024

Via Benzinga

BioLife (BLFS) Q1 2026 Earnings Transcript ↗

May 08, 2026

BioLife (BLFS) Q1 2026 Earnings Transcript

Via The Motley Fool

Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million ↗

February 27, 2026

Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology.

Via The Motley Fool

Topics Regulatory Compliance

Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗

February 27, 2026

This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.

Via The Motley Fool

Topics Regulatory Compliance

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Key Takeaways From BioLife Solns Analyst Ratings ↗

September 30, 2024

Via Benzinga

BioLife (BLFS) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

BioLife (BLFS) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

BioLife Solutions' CFO Sells 30,000 Shares ↗

December 11, 2025

This bioproduction tools provider for cell and gene therapy reported a notable insider sale.

Via The Motley Fool

Topics Regulatory Compliance

BioLife (BLFS) Q3 2025 Earnings Call Transcript ↗

November 09, 2025

BioLife (BLFS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates ↗

November 06, 2025

BioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response.

Via Chartmill

Topics Earnings

BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns ↗

August 07, 2025

BioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY.

Via Chartmill

Earnings Scheduled For March 3, 2025 ↗

March 03, 2025

Via Benzinga

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling ↗

April 19, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.